跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-FLUOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-FLUOXETINE
Authorized
STANDARD
AG-FLUOXETINE
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8db2527487251817
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
8db2527487251817
Drug Approval Canada Name
AG-FLUOXETINE
Product Name
AG-FLUOXETINE
Status
Marketed
Status Date
2023-05-15
Original Market Date
2019-03-15
Din
02485052
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB03 FLUOXETINE
Atc Name
n 06 ab 03
Aig Number
0116847003
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
FLUOXETINE (FLUOXETINE HYDROCHLORIDE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8db2527487251817
Type
Standard
Back to Health Canada Approvals